The report examines the competitive position of the European pharmaceutical companies and industries, and compares them with the pharmaceutical companies and industries in other parts of the world, particularly the US. Over the last two decades, the industry has experienced some important...

This paper explored an unusually comprehensive dataset of more than 2,000 drug R&D projects all over the world during the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the different role and comparative R&D performance of the...

Public research systems in the United States and Europe are often compared with respect to their divergent levels of involvement in the private economy. The U.S. research system, with its mix of both public and private institutions, has long played a significant role in conducting research that...